NO20076041L - Identifisering av HLA-A2-presenterte T-celleepitoper som er avledet fra onkofotalt antigen-umodent lamininreseptorprotein og anvendelser derav - Google Patents

Identifisering av HLA-A2-presenterte T-celleepitoper som er avledet fra onkofotalt antigen-umodent lamininreseptorprotein og anvendelser derav

Info

Publication number
NO20076041L
NO20076041L NO20076041A NO20076041A NO20076041L NO 20076041 L NO20076041 L NO 20076041L NO 20076041 A NO20076041 A NO 20076041A NO 20076041 A NO20076041 A NO 20076041A NO 20076041 L NO20076041 L NO 20076041L
Authority
NO
Norway
Prior art keywords
tumor
present
relates
laminin receptor
hla
Prior art date
Application number
NO20076041A
Other languages
English (en)
Norwegian (no)
Inventor
Matthias Zeis
Original Assignee
Immatics Biotechologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechologies Gmbh filed Critical Immatics Biotechologies Gmbh
Publication of NO20076041L publication Critical patent/NO20076041L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20076041A 2005-04-26 2007-11-23 Identifisering av HLA-A2-presenterte T-celleepitoper som er avledet fra onkofotalt antigen-umodent lamininreseptorprotein og anvendelser derav NO20076041L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05009095A EP1717245B1 (en) 2005-04-26 2005-04-26 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
PCT/EP2006/003888 WO2006114307A1 (en) 2005-04-26 2006-04-26 T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof

Publications (1)

Publication Number Publication Date
NO20076041L true NO20076041L (no) 2007-11-23

Family

ID=34935739

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076041A NO20076041L (no) 2005-04-26 2007-11-23 Identifisering av HLA-A2-presenterte T-celleepitoper som er avledet fra onkofotalt antigen-umodent lamininreseptorprotein og anvendelser derav

Country Status (14)

Country Link
US (1) US7968097B2 (es)
EP (2) EP1717245B1 (es)
JP (1) JP4870751B2 (es)
CN (1) CN101166759B (es)
AT (1) ATE512160T1 (es)
AU (1) AU2006239505B2 (es)
BR (1) BRPI0610841A2 (es)
CA (1) CA2606088C (es)
EA (1) EA013598B1 (es)
ES (1) ES2367643T3 (es)
NO (1) NO20076041L (es)
NZ (1) NZ563432A (es)
UA (1) UA97092C2 (es)
WO (1) WO2006114307A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004012681A2 (en) * 2002-08-02 2004-02-12 South Alabama Medical Sciences Foundation Cancer vaccines containing epitopes of oncofetal antigen
US20090004213A1 (en) * 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
NZ582823A (en) * 2007-07-27 2012-04-27 Immatics Biotechnologies Gmbh Composition of tumour-associated peptides and related anti-cancer vaccine
EP2113253B1 (en) * 2008-04-30 2010-03-31 Immatics Biotechnologies GmbH Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines
CN102574925A (zh) * 2009-03-26 2012-07-11 昆腾免疫有限公司 用于诊断及临床应用的癌胚胎抗原/未成熟层粘连蛋白受体抗体
WO2011006084A2 (en) * 2009-07-09 2011-01-13 South Alabama Medical Science Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof
CN102656263A (zh) * 2009-08-25 2012-09-05 宝生物工程株式会社 用于在视黄酸存在下制备t细胞群的方法
EP2330122A1 (en) * 2009-12-02 2011-06-08 Asklepios Kliniken Hamburg Gmbh OFA/iLRP derived modified peptide
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
EP4317432A3 (en) 2016-12-08 2024-04-17 Immatics Biotechnologies GmbH T cell receptors with improved pairing
CR20210160A (es) * 2017-04-10 2021-04-26 Immatics Biotechnologies Gmbh Péptidos y combinaciones de los mismos para el uso en la inmunoterapia contra diversos tipos de cáncer (divisional de solicitud 2019-0508)
WO2018224166A1 (en) * 2017-06-09 2018-12-13 Biontech Rna Pharmaceuticals Gmbh Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
CN112512538A (zh) * 2018-05-18 2021-03-16 国家儿童医疗中心 改进的靶向t细胞疗法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003144A1 (en) 1994-07-27 1996-02-08 The Council Of The Queensland Institute Of Medical Research Polyepitope vaccines
US6805861B2 (en) 1996-01-17 2004-10-19 Imperial College Innovations Limited Immunotherapy using cytotoxic T lymphocytes (CTL)
US20040236091A1 (en) 2001-03-28 2004-11-25 Chicz Roman M. Translational profiling
WO2004012681A2 (en) 2002-08-02 2004-02-12 South Alabama Medical Sciences Foundation Cancer vaccines containing epitopes of oncofetal antigen
CA2500687A1 (en) 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2005017102A2 (en) * 2003-05-30 2005-02-24 Diadexus, Inc. Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
WO2006014579A2 (en) * 2004-07-08 2006-02-09 The Regents Of California Enhancing class i antigen presentation with synthetic sequences

Also Published As

Publication number Publication date
EA200702202A1 (ru) 2008-04-28
CN101166759A (zh) 2008-04-23
EP1874810A1 (en) 2008-01-09
CA2606088C (en) 2015-05-26
EP1717245A1 (en) 2006-11-02
ATE512160T1 (de) 2011-06-15
CA2606088A1 (en) 2006-11-02
JP4870751B2 (ja) 2012-02-08
JP2008538901A (ja) 2008-11-13
CN101166759B (zh) 2012-09-05
US7968097B2 (en) 2011-06-28
AU2006239505B2 (en) 2012-05-10
WO2006114307A1 (en) 2006-11-02
ES2367643T3 (es) 2011-11-07
NZ563432A (en) 2010-11-26
EP1717245B1 (en) 2011-06-08
EA013598B1 (ru) 2010-06-30
UA97092C2 (ru) 2012-01-10
BRPI0610841A2 (pt) 2010-07-27
AU2006239505A1 (en) 2006-11-02
US20090041794A1 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
EA200800677A1 (ru) Опухолеассоциированные пептиды, беспорядочно связывающиеся с молекулами класса ii человеческого лейкоцитарного антигена (hla)
EA200800676A1 (ru) Опухолеассоциированные пептиды, связывающиеся с молекулами человеческого лейкоцитарного антигена (hla) i или ii класса, и относящаяся к ним противораковая вакцина
CR20200139A (es) Nueva inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (nsclc) (divisional 2016-0018)
EA200702202A1 (ru) Идентификация представленных hla-a2 т-клеточных эпитопов, полученных из раково-эмбрионального антиген-незрелого рецепторного белка ламинила, и их применение

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application